Table 3.
HR | 95% CI | P-value | |
---|---|---|---|
Gender | |||
Male |
1.0 |
|
|
Female |
0.75 |
0.72-0.78 |
<0.001 |
Race/ethnicity |
|
|
|
Non-Hispanic white |
1.0 |
|
|
Non-Hispanic black |
0.82 |
0.78-0.86 |
<0.001 |
Hispanic |
1.16 |
1.09-1.22 |
<0.001 |
Other |
1.25 |
1.16-1.35 |
<0.001 |
ZIP code-level income quartile | |||
>75th percentile |
1.0 |
|
|
50-75th percentile |
0.90 |
0.86-0.95 |
<0.001 |
25-50th percentile |
0.85 |
0.81-0.89 |
<0.001 |
<25th percentile |
0.72 |
0.68-0.76 |
<0.001 |
Primary cause of ESRD | |||
Diabetes |
1.0 |
|
|
Hypertension |
1.28 |
1.22-1.34 |
<0.001 |
Glomerular |
2.50 |
2.38-2.62 |
<0.001 |
Cystic |
2.99 |
2.75-3.24 |
<0.001 |
Other |
1.37 |
1.29-1.45 |
<0.001 |
Unknown |
1.46 |
1.33-1.61 |
<0.001 |
Co-morbid conditionsb | |||
Congestive heart failure |
0.59 |
0.56-0.62 |
<0.001 |
Ischemic heart disease |
0.68 |
0.64-0.72 |
<0.001 |
Cerebrovascular accident |
0.60 |
0.54-0.65 |
<0.001 |
Peripheral vascular disease |
0.68 |
0.63-0.73 |
<0.001 |
Chronic obstructive pulmonary disease |
0.47 |
0.42-0.53 |
<0.001 |
Tobacco abuse |
0.84 |
0.78-0.91 |
<0.001 |
Drug dependence |
0.35 |
0.29-0.39 |
<0.001 |
Cancer |
0.33 |
0.29-0.39 |
<0.001 |
HIV no AIDS |
0.09 |
0.04-0.18 |
<0.001 |
HIV with AIDS |
0.65 |
0.54-0.78 |
<0.001 |
Non-ambulatory | 0.32 | 0.26-0.39 | <0.001 |
aESRD networks not shown.
bReference = no condition.